A Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir in Combination With Rifampin in HIV-1-infected Patients With Tuberculosis
Phase of Trial: Phase IV
Latest Information Update: 17 May 2019
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Rifampicin (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 May 2019 Status changed from active, no longer recruiting to discontinued.
- 13 Dec 2018 Planned End Date changed from 1 Mar 2019 to 1 May 2019.
- 13 Dec 2018 Status changed from recruiting to active, no longer recruiting.